The rs3804099 variants may reduce TLR-2-related chronic inflammation and induce apoptosis (Kim and Karin, 2011; Semlali et al., 2017; Mohamed et al., 2020), resulting in decreased risk of GC. This evidence concerns the gene TLR2 and gastric cancer.